...
首页> 外文期刊>Pain Physician >Resistin Gene Polymorphism Is an Influencing Factor of Postoperative Pain for Chinese Patients
【24h】

Resistin Gene Polymorphism Is an Influencing Factor of Postoperative Pain for Chinese Patients

机译:抵抗素基因多态性是中国患者术后疼痛的影响因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Gene polymorphism is an important factor affecting the efficacy and dosage of opioids. A recent study showed RETN rs3745367 was associated with postoperative pain intensity. OPRM1 gene was confirmed to affect the postoperative analgesic consumption of morphine and other opioids.OBJECTIVE: In this study, we investigated the association between single nucleotide polymorphisms (SNPs) in the RETN, OPRM1 gene and postoperative pain intensity, analgesics consumption, and ADR. The haplotype analysis focus on OPRM1 was also implemented.STUDY DESIGN: This was a prospective, observational study. SETTING: Patients undergoing spinal fusion and correction operation were recruited. Genotypes of rs3745367, rs1799971, rs2075572, and rs9322447 were tested. Pain assessment was performed to measure postoperative pain intensity, postoperative fentanyl and pethidine consumption was recorded to calculate analgesics consumption, and adverse reactions were recorded.METHOD: We recruited 142 patients undergoing spinal correction and fusion. Genotyping was performed by using a real-time polymerase chain reactions (PCRs) system and validated with allelic discrimination assays. The pain was assessed using a numerical rating scale (NRS). Statistical analyses were performed using SPSS software. LD test and the construction and analysis of haplotype were using Haploview software. RESULTS: Rs3745367 demonstrated a significant association with postoperative average pain intensity in 24h (P = 0.015) and 48h (P = 0.001) after surgery. Rs2075572 and rs9322447 influenced postoperative maximal pain intensity in 48h after surgery (P = 0.042, 0.033, respectively). No correlation was found between OPRM1 SNPs and analgesics consumption and adverse reaction. According to the results of this study, a strong LD was observed between rs1799971 and rs9322447 (Block 1, LD parameters: D’ = 0.82, r2 = 0.14), rs2075572 and rs9322447 (Block 2, LD parameters: D’ = 0.92, r2 = 0.51).LIMITATIONS: The association between rs3745367 with serum resistin levels was not investigated in this research, serum resistin levels of the incision part should be investigated in future studies. Conclusion: RETN rs3745367 was associated with postoperative average pain intensity, OPRM1 rs2075572 and rs9322447 may influence postoperative maximal pain intensity.
机译:背景:基因多态性是影响阿片类药物疗效和剂量的重要因素。最近的一项研究显示RETN RS3745367与术后疼痛强度有关。确认OPRM1基因影响吗啡和其他阿片类药物的术后镇痛消费。目的:在这项研究中,我们研究了RetN,OPRM1基因和术后疼痛强度,镇痛药消耗和ADR之间的单核苷酸多态性(SNP)之间的关联。对OPRM1的单倍型分析专注于OPRM1。Study Design:这是一项潜在的观察性研究。设置:招募了接受脊髓融合和校正操作的患者。测试了RS3745367,RS1799971,RS2075572和RS9322447的基因型。进行疼痛评估以测量术后疼痛强度,记录术后芬太尼和哌替啶消费以计算镇痛药消耗,并记录不良反应。方法:我们招募了142名接受脊髓矫正和融合的患者。通过使用实时聚合酶链反应(PCRS)系统进行基因分型并用等位基因辨别测定验证。使用数值额定尺度(NRS)评估疼痛。使用SPSS软件进行统计分析。 LD测试和单倍型的构建和分析使用Haploview软件。结果:RS3745367在手术后24h(p = 0.015)和48h(p = 0.001)中的术后平均疼痛强度展示了显着关联。 rs2075572和rs9322447在手术后48h的术后最大疼痛强度影响(p = 0.042,0.033)。 OPRM1 SNP和镇痛药消耗和不良反应之间没有发现任何相关性。根据本研究的结果,在RS1799971和RS932447之间观察到强LD(框1,LD参数:D'= 0.82,R2 = 0.14),RS2075572和RS9322447(框2,LD参数:D'= 0.92,R2 = 0.51).Limitations:在本研究中未研究RS3745367与血清抵抗素水平之间的关联,在未来的研究中应调查切口部分的血清抵抗素水平。结论:RETN RS3745367与术后平均疼痛强度有关,OPRM1 RS2075572和RS9322447可能影响术后最大疼痛强度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号